Tag: Schizophrenia

In a new study published in the Journal of Clinical Psychology, researchers tested how well “ontological insecurity” predicted psychotic-like experiences (PLEs). They found that...

During a period of self-doubt, I chose to see a psychiatrist because I was engulfed in negative thoughts and couldn't find a direction in life. The slightest joys came only when I was high. Though my weed addiction was likely causing all of my symptoms, my psychiatrist’s response was to prescribe antipsychotics.

There is a lack of consensus in the definition of ‘relapse’ across randomized controlled trials of antipsychotic maintenance treatment for schizophrenia and psychosis.

Research finds patients of first-episode psychosis report benefits from social relationships where their personhood is respected.

The story of the Genain quadruplets has long been cited as evidence proving something about the supposed hereditary nature of schizophrenia. But who wouldn’t fall apart after surviving a childhood like theirs? The doctors attributed their problems to menstrual difficulties or excessive masturbation — anything except abuse.

The alternative treatment model of Soteria helps individuals suffering from schizophrenia without relying on medication or coercion.

A new attempt to study the neurological effects of long-term exposure to antipsychotics uses healthy volunteers on minimal doses for 15 days.

Recovery is not a bridge we cross and never return to. Rather, it is more like crossing a stream we ford by side-stepping on different stones. Not all of the stones are as sturdy as some of the others. Yes, we slip at times, only to regain our footing and forge ahead.

Researchers review nine previously studied psychosocial approaches and call for more high-quality trials treating schizophrenia with minimal to no antipsychotics.

Study explores the emotional and embodied experience of individuals undergoing a first crisis in psychosis.

The approval of the digital antipsychotic may open the door for more pharmaceutical company profits without evidence of benefits to patients.

A study, recently published in Psychological Medicine, examined the cognitive functioning of individuals with schizophrenia who discontinued antipsychotics, and those who maintained their antipsychotic...

A new study, published in the journal Psychosis: Psychological, Social and Integrative Approaches, explores ways that metaphor operates in the lived-experiences of individuals who...

New qualitative study seeks to examine the implementation of the Open Dialogue approach in the UK.

Understanding schizophrenia as a non-enigmatic, understandable human experience goes against a history of institutional “othering” that has sustained psychiatric legitimacy and further marginalized service-users.

Researchers question biases of preliminary trials that found that sodium nitroprusside, an antihypertensive drug, has positive effects on schizophrenia symptoms.

Researchers detect disparity between white and African American patients diagnosed with schizophrenia when symptoms of a mood disorder are present.

The authors outline reasons for renaming schizophrenia and the way a change can reform practice.

A new study examines the effects of CBD as an adjunct therapy to antipsychotic medication for patients diagnosed with schizophrenia.

Review compares the effectiveness of pharmacological and non-pharmacological interventions for improving physical health outcomes in people diagnosed with schizophrenia.

A new study has found that of 10 people who were fully recovered from their first episode of schizophrenia (FES), those not taking antipsychotics did better in terms of cognitive, social, and role functioning—and reached full recovery more quickly.

Researchers discuss the evidence that antipsychotic medications may cause brain atrophy in children, whose brains are still developing.

A new analysis of antipsychotic treatment of schizophrenia (published in Schizophrenia Bulletin) has found that two-thirds of patients treated this way do not experience symptom remission.

Researchers review the risks and benefits of deprescribing from antipsychotic drugs and advocate for a patient-centered approach to tapering.

From Reuters, "'At La Fageda, these people don’t have a label – they are totally integrated – and they start improving, reconstructing themselves without...